Kamaria T. Jacobs

Kamaria T. Jacobs

Auto-generated profile, based on publicly available information

Kamaria T. Jacobs

Institute of Public Health, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, Florida

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2024 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
QLQinran Liu
Qinran Liu
HMHeidy N. Medina
Heidy N. Medina
EREstelamari Rodriguez
Estelamari Rodriguez
KJKamaria T. Jacobs
Kamaria T. Jacobs
CBClyde Brown
Clyde Brown
PPPaulo Pinheiro
Paulo Pinheiro
Background: Despite the increasing adoption of stereotactic body radiotherapy (SBRT) as a recommended alternative for early-stage non–small cell lung cancer (NSCLC), population-based research on racial/ethnic disparities in curative-intent treatment accounting for SBRT remains limited. This study investigated trends and disparities in receiving curative-intent surgery and/or SBRT in a diverse, retrospective cohort. Methods: Early-stage NSCLC cases (2005–2017) from the Florida cancer registry were linked to individual-level statewide discharge data containing comorbidities and specific treatment information. Joinpoint regression assessed trends in treatment receipt. Multivariable logistic regression examined associations between race/ethnicity and treatment type. Results: Among 64,999 patients with early-stage NSCLC, 71.6% received curative-intent treatment (surgery and/or SBRT): 73.1%, 72.4%, and 60.3% among Hispanic, White, and Black patients, respectively (P < 0.01). SBRT use increased steeply from 2005 to 2007 and then by 7.9% annually from 2007 to 2017 (P < 0.01); curative-intent surgery remained stable from 2005 to 2014 before declining by 6.2% annually during 2014–2017 (P = 0.04). The Black-White disparity in receipt of curative-intent treatment was significant [ORadj, 0.65; 95% confidence interval (CI), 0.60–0.71]. Patients with Charlson comorbidity index (CCI)≥3 had 36% (ORadj, 0.64; 95% CI, 0.60–0.69) lower odds of receiving curative-intent surgery and no significant difference for SBRT (ORadj, 1.06; 95% CI, 0.93–1.20) compared with CCI = 0. Conclusions: Racial disparities in receiving curative-intent treatment for early-stage NSCLC persist despite the availability of SBRT, suggesting the full potential of curative-intent treatment for early-stage NSCLC remains unachieved. Impact: Addressing disparities in early-stage NSCLC requires addressing differential treatment patterns and enhancing accessibility to treatments like underutilized SBRT, particularly for high-comorbidity populations such as Black patients.

3 April 2024
Verified
Other
Open access
PDF file
QLQinran Liu
Qinran Liu
HMHeidy N. Medina
Heidy N. Medina
EREstelamari Rodriguez
Estelamari Rodriguez
KJKamaria T. Jacobs
Kamaria T. Jacobs
CBClyde Brown
Clyde Brown
PPPaulo Pinheiro
Paulo Pinheiro
Supplementary Table S6 shows the determinants of receipt of curative-intent surgery and receipt of any curative-intent treatment in Hispanic subgroups in Florida from 2005 to 2017.

3 April 2024
Verified
Other
Open access
PDF file
QLQinran Liu
Qinran Liu
HMHeidy N. Medina
Heidy N. Medina
EREstelamari Rodriguez
Estelamari Rodriguez
KJKamaria T. Jacobs
Kamaria T. Jacobs
CBClyde Brown
Clyde Brown
PPPaulo Pinheiro
Paulo Pinheiro
Supplementary Table S3 shows the determinants of patients who only received SBRT by CCI in Florida from 2005 to 2017.

3 April 2024
Verified
Other
Open access
PDF file
QLQinran Liu
Qinran Liu
HMHeidy N. Medina
Heidy N. Medina
EREstelamari Rodriguez
Estelamari Rodriguez
KJKamaria T. Jacobs
Kamaria T. Jacobs
CBClyde Brown
Clyde Brown
PPPaulo Pinheiro
Paulo Pinheiro
Supplementary Table S4 shows the full list of determinants of receipt of curative surgery and any curative-intent treatment in Florida from 2005 to 2017.

3 April 2024
Verified
Other
Open access
PDF file
QLQinran Liu
Qinran Liu
HMHeidy N. Medina
Heidy N. Medina
EREstelamari Rodriguez
Estelamari Rodriguez
KJKamaria T. Jacobs
Kamaria T. Jacobs
CBClyde Brown
Clyde Brown
PPPaulo Pinheiro
Paulo Pinheiro
Supplementary Table S5 shows the stratification analyses of receipt of curative-intent surgery and receipt of any curative-intent treatment by region in Florida from 2005 to 2017.

3 April 2024
Verified
Other
Open access
PDF file
QLQinran Liu
Qinran Liu
HMHeidy N. Medina
Heidy N. Medina
EREstelamari Rodriguez
Estelamari Rodriguez
KJKamaria T. Jacobs
Kamaria T. Jacobs
CBClyde Brown
Clyde Brown
PPPaulo Pinheiro
Paulo Pinheiro
Supplementary Table S5 shows the stratification analyses of receipt of curative-intent surgery and receipt of any curative-intent treatment by region in Florida from 2005 to 2017.